The bicyclic molecule indole has been in the limelight because of its numerous
pharmacological potencies. It is used as an excellent scaffold in drug discovery of medicinal …

Globally, more than 58 million people are chronically infected with Hepatitis C virus (HCV)
with 1.5 million new infections occurring each year. An effective vaccine for HCV is therefore …

Abstract Treatment of emerging RNA viruses is hampered by the high mutation and
replication rates that enable these viruses to operate as a quasispecies. Declining honey …

Hepatitis C virus (HCV) has a very narrow species and tissue tropism and efficiently
replicates only in humans and the chimpanzee. Recently, several studies identified close …

Hepatitis C virus (HCV) vaccines, designed to augment specific T-cell responses, have been
designated as an important aspect of effective antiviral treatment. However, despite the …

Viral hepatitis is a major public health concern in China, but data on national
epidemiological characteristics are lacking. We collected reporting incidence data on …

Hepatitis C virus (HCV) infection has become a global health problem with enormous risks.
Nonstructural protein 5B (NS5B) RNA-dependent RNA polymerase (RdRp) is a component …

Abstract Background Hepatitis B and C are silent killers not yet recognized as major public
health challenges in many developing countries with huge disease burden. In Ethiopia …

Abstract Hepatitis C Virus (HCV) infection is a major cause of chronic liver disease,
hepatocellular carcinoma, and the single most common indication for liver transplantation …

Nanoscale materials can improve the efficacy of vaccines. Herein we review latest
developments that use nanomaterials for vaccines. By highlighting the relationships …